G

GT Biopharma
D

GTBP

6.92000
USD
0.85
(14.00%)
مفتوح الان
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
200
الربح لكل سهم
-11
العائد الربحي
-
P/E
0
حجم السوق
12,486,303
نظرة عامة
أصول ذات صلة
ABBV
ABBV
D
شركة أب في
288.59
3.79(1.34%)
AMZN
AMZN
D
أمازون
253.990
-0.685(-0.27%)
AZN
AZN
D
أسترازينيكا
168.360
6.590(4.07%)
BMY
BMY
D
Bristol-Myers Squibb Co
61.350
2.080(3.51%)
GSK
GSK
D
GSK plc
49.540
1.665(3.48%)
MRK
MRK
D
ميرك اند كو
150.690
3.055(2.07%)
NVS
NVS
D
نوفارتس AG
151.220
4.240(2.89%)
PFE
PFE
D
فايزر
29.680
0.435(1.49%)
REGN
REGN
D
Regeneron Pharmaceuticals
799.61
20.34(2.61%)
المزيد

العنوان: GT Biopharma Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.